ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARP Annual Meeting 2019

Abstract Number: 1779

CLEC5A/MDL-1 Is Critical for Inflammatory Arthritis and Skin Inflammation

Cuong Nguyen1, Dai Hui 1, Ran Gu 1, Trevor Chan 2, Alina Marleev 3, Emanual Maverakis 3, Vijay Kuchroo 4, Shie-Liang Hsieh 5, Ilias Tagkopoulos 2, Christopher Ritchlin 6 and Iannis Adamopoulos 1, 1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Sacramento, CA, 2University of California, Davis, Department of Computer Science, California, USA, Davis, CA, 3Department of Dermatology, School of Medicine, UCD, Sacramento, California, USA., Sacramento, CA, 4Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, MA, USA, Boston, MA, 5Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei, Taiwan, Taipei, Taiwan (Republic of China), 6Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARP Annual Meeting 2019

Keywords: arthritis and psoriatic arthritis, Interleukin-23, MDL-1, skin inflammation

Session Information

Date: Monday, November 11, 2019

Title: 4M095: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1776–1781)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Interleukin-23 (IL-23) and its cognate receptor interleukin-23R (IL-23R):IL-12Rβ1 plays a critical role in the pathogenesis of autoimmune diseases including psoriasis and psoriatic arthritis. Although significance of IL-23 signaling in adaptive immunity has been well-studied, the role of IL-23 in myeloid cell activation remains unknown.

Methods: To investigate role of CLEC5A/MDL-1 in psoriatic arthritis-like pathology, we performed in vivo gene transfer of IL-23 in WT, IL-23RGFP reporter, and Mdl-1-/- mice. qRT-PCR, RNAseq, Western blot, flow cytometry, ELISA, H&E stain, and immunofluorescence staining methods were used to analyze the phenotype of WT and transgenic mice.

Results: Herein, we show in the IL-23RGFP reporter mice, that IL-23 induces the expansion of myeloid cell populations including an epidermal myeloid DNAX activation protein 12 (DAP12)-associating lectin-1 (MDL-1)+CD11b+Ly6G+IL-23R+ cell population associated with epidermal hyperplasia and an MDL-1+CD11b+Ly6ChighIL-23R+ associated with bone destruction. Mechanistically, genetic ablation of MDL-1 prevented IL-23-gene transfer elicited myelopoiesis and showed a marked reduction of skin inflammation markers (K16, S100a7, S100a8, S100a9, Cxcl-1, Cxcl-2) and bone destruction markers (Acp5, Ctsk, Mmp9) compared to wildtype mice. Moreover, we found that Mdl-1-/- mice had significantly higher bone mass and impaired osteoclast differentiation in vitro and in vivo as well as reduced joint inflammation in IL-23 gene transfer induced arthritis. Mechanistic data through of flow cytometry, Western blotting and co-immunoprecipitation experiments revealed that a trimeric complex of IL-23R/DAP12/MDL-1 elicited the associated pathologies in our murine model. Furthermore, we performed RNAseq analysis of murine skin following IL-23 gene transfer and revealed 297 differentially expressed genes (DEGs) affected by MDL-1 deletion. Specifically, these DEGs are associated with myelopoiesis, neutrophil proteases, DAP12, cell survival and apoptosis. We correlated our findings with RNAseq meta-analyses derived from human psoriatic skin (135 patients vs 133 controls), which showed elevation of MDL-1 in psoriatic patients and positive correlation for IL-23 versus MDL-1 and IL-23R versus MDL-1.

Conclusion: Collectively, our data demonstrate that MDL-1 is a critical component of IL-23 signaling that dictates synovial and skin inflammation in vivo, and could be targeted for the treatment of PsA.


Disclosure: C. Nguyen, None; D. Hui, None; R. Gu, None; T. Chan, None; A. Marleev, None; E. Maverakis, None; V. Kuchroo, None; S. Hsieh, None; I. Tagkopoulos, None; C. Ritchlin, AbbVie, 2, 5, 9, Amgen, 2, 5, BMS, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Lilly, 5, Novartis, 5, Pfizer, 2, Pfizer Inc, 5, UCB, 2, 5; I. Adamopoulos, None.

To cite this abstract in AMA style:

Nguyen C, Hui D, Gu R, Chan T, Marleev A, Maverakis E, Kuchroo V, Hsieh S, Tagkopoulos I, Ritchlin C, Adamopoulos I. CLEC5A/MDL-1 Is Critical for Inflammatory Arthritis and Skin Inflammation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/clec5a-mdl-1-is-critical-for-inflammatory-arthritis-and-skin-inflammation/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clec5a-mdl-1-is-critical-for-inflammatory-arthritis-and-skin-inflammation/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology